ImmuniWeb® Continuous Penetration Testing is a commercial penetration testing solution by ImmuniWeb. Whonow is a free penetration testing solution. Features, integrations, deployment and the company behind each one, side by side.
Continuous pentesting service monitoring web apps & APIs for code changes
A malicious DNS server that executes DNS Rebinding attacks on-demand to bypass same-origin policy restrictions and access internal network resources.
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
ImmuniWeb® Continuous Penetration Testing fits if you want a cloud product and you are a small business.
Whonow fits if you need to run it on your own servers, you need a free product and you want an open-source product.
Common questions when comparing ImmuniWeb® Continuous Penetration Testing vs Whonow for penetration testing.
ImmuniWeb® Continuous Penetration Testing: Continuous pentesting service monitoring web apps & APIs for code changes. Built by ImmuniWeb.
Whonow: A malicious DNS server that executes DNS Rebinding attacks on-demand to bypass same-origin policy restrictions and access internal network resources.
The table above shows where their features, integrations, deployment and company size fit differ.
ImmuniWeb® Continuous Penetration Testing is made by ImmuniWeb. Whonow is open-source with 654 GitHub stars. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. ImmuniWeb® Continuous Penetration Testing and Whonow are both Penetration Testing products. Key differences: ImmuniWeb® Continuous Penetration Testing is Commercial while Whonow is Free, Whonow is open-source. Use the table above to see where features, deployment and company size fit differ.
